CIK 1622627
Rosalind Advisors, Inc.
Institutional 13F holdings & portfolio
Holdings
42
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–42 of 42
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | 3.3M | $1M+ | SH |
| SVRA | SAVARA INC | 3.4M | $1M+ | SH |
| FENC | FENNEC PHARMACEUTICALS INC | 2.6M | $1M+ | SH |
| XERS | XERIS BIOPHARMA HOLDGS INC | 2.1M | $1M+ | SH |
| VRDN | VIRIDIAN THERAPEUTICS INC | 450K | $1M+ | SH |
| MDWD | MEDIWOUND LTD | 749K | $1M+ | SH |
| VSTM | VERASTEM INC | 1.8M | $1M+ | SH |
| REPL | REPLIMUNE GROUP INC | 1.4M | $1M+ | SH |
| ATYR | ASTRIA THERAPEUTICS INC | 1.0M | $1M+ | SH |
| HELP | CYBIN INC | 1.7M | $1M+ | SH |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 690K | $1M+ | SH |
| CGON | CG ONCOLOGY INC | 300K | $1M+ | SH |
| CYTK | CYTOKINETICS INC | 195K | $1M+ | SH |
| XFOR | X4 PHARMACEUTICALS INC | 2.6M | $1M+ | SH |
| DFTX | MIND MEDICINE MINDMED INC | 750K | $1M+ | SH |
| PROF | PROFOUND MEDICAL CORP | 1.1M | $1M+ | SH |
| NSPR | INSPIREMD INC | 3.9M | $1M+ | SH |
| OCUL | Ocular Therapeutix, Inc | 400K | $1M+ | SH |
| AVBP | ARRIVENT BIOPHARMA INC | 216K | $1M+ | SH |
| TLPH | TALPHERA INC | 3.6M | $1M+ | SH |
| MYO | MYOMO INC | 3.8M | $1M+ | SH |
| — | INVESCO QQQ TR | 450K | $1M+ | SH (Put) |
| PYPD | POLYPID LTD | 697K | $1M+ | SH |
| OKUR | ONKURE THERAPEUTICS INC | 730K | $1M+ | SH |
| — | SPDR S&P 500 ETF TR | 510K | $1M+ | SH (Put) |
| — | ANAVEX LIFE SCIENCES CORP | 1.2M | $1M+ | SH (Put) |
| RGNT | REGENTIS BIOMATERIALS LTD | 252K | $1M+ | SH |
| — | SPDR SERIES TRUST | 1.9M | $1M+ | SH (Put) |
| TRVI | TREVI THERAPEUTICS INC | 100K | $1M+ | SH |
| — | ISHARES TR | 200K | $1M+ | SH (Put) |
| NRXS | NEURAXIS INC | 286K | $1M+ | SH |
| KURA | KURA ONCOLOGY INC | 100K | $1M+ | SH |
| GUTS | FRACTYL HEALTH INC | 386K | $500K+ | SH |
| BFRI | BIOFRONTERA INC | 1.1M | $500K+ | SH |
| — | ARRIVENT BIOPHARMA INC | 108K | $500K+ | SH (Call) |
| — | VERASTEM INC | 269K | $100K–$500K | SH (Call) |
| — | UNIQURE NV | 100K | $50K–$100K | SH (Call) |
| — | REPLIMUNE GROUP INC | 231K | $1K–$15K | SH (Call) |
| — | VIKING THERAPEUTICS INC | 100K | $1K–$15K | SH (Call) |
| — | VISTAGEN THERAPEUTICS INC | 493K | N/A | SH (Call) |
| — | REPLIMUNE GROUP INC | 265K | N/A | SH (Put) |
| — | REZOLUTE INC | 263K | N/A | SH (Call) |